EPISODE · May 14, 2026 · 20 MIN
Adjuvant Durvalumab and the Future of Early-Stage NSCLC
from Journal of Clinical Oncology (JCO) Podcast
Guest Dr. Glenwood Goss and host Dr. Davide Soldato discuss JCO article, "Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer" and the implications of minimal residual disease, results regarding the efficacy of immunotherapy in the adjuvant setting, and the evolving strategies for patient care in lung cancer treatment. LINK TO FULL TRANSCRIPT
NOW PLAYING
Adjuvant Durvalumab and the Future of Early-Stage NSCLC
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m